Chloramphenicol Induces Abnormal Differentiation and Inhibits Apoptosis in Activated T Cells
Authors:
Open Access
- 15 June 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (12) , 4875-4881
Abstract
Chloramphenicol is a broad-spectrum antibiotic used for the treatment of many infectious diseases and has become one of the major seafood contaminants. Hematologic disorders such as aplastic anemia and leukemia induced by chloramphenicol are a major concern. However, the mechanism underlying chloramphenicol-induced leukemogenesis is not known. By investigating the effects of chloramphenicol on the activation of mouse T cells stimulated with anti-CD3 antibody or staphylococcal enterotoxin B, we found that chloramphenicol induces the differentiation of activated T cells into lymphoblastic leukemia-like cells, characterized by large cell size, multiploid nuclei, and expression of CD7, a maker for immature T cells and T-cell lymphocytic leukemia, thus phenotypically indicating differentiation toward leukemogenesis. High expression of cyclin B1, but not p53, c-myc, and CDC25A, was detected in chloramphenicol-treated activated T cells, which may relate to abnormal cell differentiation. Chloramphenicol inhibited the activation-induced cell death of mouse and human T-cell receptor–activated T cells by down-regulating the expression of Fas ligand. Our findings show that abnormal cell differentiation and inhibition of apoptosis may contribute to the development of leukemia associated with clinical applications of chloramphenicol. [Cancer Res 2008;68(12):4875–81]Keywords
This publication has 34 references indexed in Scilit:
- E2F4 Function in G2 Maintaining G2-arrest to Prevent Mitotic Entry with Damaged DNACell Cycle, 2007
- Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cellsBlood, 2005
- Multinucleation of koilocytes is in fact multilobation and is related to aberration of the G2 checkpointJournal of Clinical Pathology, 2005
- Recycling the Cell CycleCell, 2004
- Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries?Archives of Disease in Childhood, 2003
- Epidemiologic, clinical and laboratory features of scrub typhus in thirty Thai childrenThe Pediatric Infectious Disease Journal, 2003
- Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiationOncogene, 2000
- Flow Cytometry Study of Human Cyclin B1 and Cyclin E Expression in Leukemic Cell Lines: Cell Cycle Kinetics and Cell LocalizationExperimental Cell Research, 1999
- Risks of Non-Hodgkinʼs Lymphoma, Multiple Myeloma, and Leukemia Associated with Common MedicationsEpidemiology, 1996
- Interaction of Chloramphenicol and Metabolites with Colony Stimulating Factors: Possible Role in Chloramphenicol-Induced Bone Marrow InjuryThe American Journal of the Medical Sciences, 1990